>
pdufa.bio

Dextromethorphan-Bupropion

Updated ยทnext FDA decision on the calendar

Dextromethorphan-Bupropion is a Cognition Therapeutics Inc program. Its next catalyst is a Readout in May 2027. Every date links its source.

CGTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Cognition Therapeutics Inc (CGTX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · May 2027CGTX

Questions

When is Dextromethorphan-Bupropion's next FDA decision or readout?

The next tracked catalyst for Dextromethorphan-Bupropion is a Readout in May 2027.

What happened at Dextromethorphan-Bupropion's most recent FDA decision?

No FDA decision for Dextromethorphan-Bupropion is in our archive yet.

Who makes Dextromethorphan-Bupropion?

Cognition Therapeutics Inc (CGTX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.